Longitudinal Analysis of Patient Reported Quality of Life in Newly Diagnosed Chronic Lymphocytic Leukemia Stratified By Initial Management Strategy: A Multi-Institutional Prospective Cohort Study

Introduction: The treatment of chronic lymphocytic leukemia (CLL) has evolved over the past two decades, from finite duration chemoimmunotherapy (CIT) to an era of targeted agents such as Bruton Tyrosine Kinase (BTK) inhibitors, BCL2 inhibitors, and anti-CD20 monoclonal antibodies. Little is known a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.498-498
Hauptverfasser:	Koehler, Amber, Noble, Brie N., Call, Timothy G., Parikh, Sameer A., Shanafelt, Tait D., Tsang, Mazie, Bommier, Côme, Rabe, Kari G., Strouse, Christopher, Thompson, Carrie, Hampel, Paul J., Yost, Kathleen, Larson, Melissa C., Slager, Susan L., Link, Brian K., Cerhan, James R., Dueck, Amylou Constance
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!